The Lost Vocation of Medicine: From Calling to Commodity by Joseph Varon at Brownstone Institute When I was a young medical student, I believed with all my heart that medicine was the highest calling a human being could answer. We were not just training to earn a degree or secure a position. We were stepping into a lineage, inheriting a tradition that stretched back to Hippocrates, Galen, Vesalius, Osler, and countless others who saw the care of the sick as a sacred covenant. Every time I wal...| Brownstone Institute
Antidepressants Increase 130% for Teen Girls, Drop 7% For Boys by Roger McFillin at Brownstone Institute Let me ask you something. What are the odds that one-third of American adolescents suddenly developed a disease requiring drugs that carry a BLACK BOX WARNING for suicide? What mysterious plague swept through middle and high schools demanding 8.3 million kids be put on medications that literally more than double their risk of killing themselves? And here’s where it gets truly insane: Thi...| Brownstone Institute
Strategy over Optics: Trump’s Most Favored Nation Status on Drug Prices by James Lyons-Weiler at Brownstone Institute On September 30, 2025, the image of Albert Bourla standing in the White House beside President Donald J. Trump stunned large segments of the public. The moment instantly became a lightning rod, drawing condemnation and confusion from those who remembered the unresolved—and in many cases, still unaccounted for—devastations of the Covid-19 response. My inbox, and those of ...| Brownstone Institute
A Giant in Medicine: Tribute to Drummond Rennie by Peter C. Gøtzsche at Brownstone Institute Nephrologist Drummond Rennie died on 12 September 2025, aged 89. He was deputy editor at the New England Journal of Medicine and at JAMA, for a total of 36 years. Drummond’s key interest was to improve the quality of medical research. He made numerous outstanding contributions to science and received the 2008 Award for Scientific Freedom and Responsibility by the American Association for the Adva...| Brownstone Institute
The Coup, the Calamity, and the Conspiracy by Jeffrey A. Tucker at Brownstone Institute A website specializing in data visuals offered a helpful graphic on global inflation, 2020-2025, with no other comment about how or why this happened. The results are eye-popping and amazing, and a reminder that hardly anyone has fully come to terms with what transpired over five years. Most currencies in the world took a 25-35 percent haircut, Far East excepted. That’s a technical description that obs...| Brownstone Institute
Withheld: Real-World Infant Deaths from RSV Antibody Shot by Yaffa Shir-Raz at Brownstone Institute As ACIP deliberated without access to full trial data, an even more alarming pattern was already unfolding in the real world. Now, analysis of the FDA’s FAERS database reveals 37 infant deaths out of just 991 reports – a fatality signal nearly twice that of other routine vaccines. Why was this not disclosed? The warning sign was already visible in the clinical trials: infant deaths in the t...| Brownstone Institute
We build Day-1/100 plans, harmonize quality/GxP, rationalize portfolios, optimize manufacturing and supply networks, and track synergies with a disciplined IMO/PMO. The post Pharmaceutical M&A Integration: Synergy Realization & Savings appeared first on NMS Consulting.| NMS Consulting
A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD. The post Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot appeared first on The Daily Upside.| The Daily Upside
It’s becoming increasingly clear that minimal signal detection is not cutting it, when it comes to doing the best for patients and staying ahead of... The post Statistical Significance: Could Small Pharma Companies be making more of Safety Signal Detection? appeared first on .|
Our interview series is here to deliver you digestible intelligence from the organizations and innovators leading the world of AI in healthcare - through expert and in-depth interviews.| AI Accelerator Institute
Revolutionizing Pharma Supply Chains: How RTLS Ensures Compliance and Traceability in 2025 In the dynamic pharmaceutical industry, where patient safety hinges on unwavering precision, supply chain management is under intense scrutiny. As of September 2025, regulatory pressures are intensifying globally, with frameworks like the U.S. FDA's Drug Supply Chain Security Act (DSCSA) now in| Ubisense
GSK has announced a $30 billion commitment to expand R&D and manufacturing capacity in the US over the next decade. The focus: biologics, vaccines, and oncology. The post GSK joins industry push with $30B plan for US drug production appeared first on Manufacturing Today.| Manufacturing Today
Eli Lilly's newest facility in Concord, Virginia, could redefine how pharmaceutical companies think about scale, security, and supply chains. The post Eli Lilly invests $5B in Virginia in a new US hub for drug manufacturing appeared first on Manufacturing Today.| Manufacturing Today
BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.” The post Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus appeared first on The Daily Upside.| The Daily Upside
The Perception of Reality by Russ Gonnering at Brownstone Institute Ten years ago, the internet was completely captured by “The Dress.” A photoof a dress was displayed.Was it Blue and Black? Was it White and Gold? Everybody had an opinion, and it was definite. This is distinct from other optical illusions, such as The Rubin Vase, which can be easily reversed by most people: The Dress launched a flurry of scientific inquiries in an attempt to explain the science behind this. The Journal of...| Brownstone Institute
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive. The post Why Pharma Must Rethink How It Explains the Vaccine Schedule—Not Just Defend It appeared first on maslansky+partners.| maslansky+partners
We have heard slogan “safe and effective” ad nauseum in relation to vaccines — repeated by health agencies, media, pharmaceutical companies.| Brownstone Institute
Nobel Prize narrative is not harmless compliment. It is calculated effort to sanctify one pillar, while the others collapse beneath evidence.| Brownstone Institute
With the Ministry of Health’s latest pledge to improve upon medical legislation, international businesses continue to pin high hopes on marketing authorisation regulations for medical devices and distribution rights in order to drive their plans forward.| Vietnam Investment Review - VIR
The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Examining generative AI in healthcare: innovations, consumer views, and pressing ethical considerations.| AI Accelerator Institute
Real-world insights from the front lines of clinical AI| AI Accelerator Institute
Prior to her time at Lightstone, Gaynor worked at a number of early-stage medical device start-ups, spending more than a decade in pharma.| Silicon Republic
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.| MedCity News
The Parkinson’s disease market across 7MM is forecast to grow at a CAGR of 7.6% from $3.4 billion in 2023 to $7.0 billion in 2033, according to GlobalData.| GlobalData
America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme, despite securing major concessions 20 years ago.| www.abc.net.au
Which Location Tracking Technology is Best for Pharmaceutical Manufacturing & Labs? In pharmaceutical manufacturing and laboratory environments, precision isn’t optional — it’s essential. The margin for error is incredibly slim. A single misplaced piece of equipment, the unplanned absence of a technician, or an error in timing can ruin an entire batch or compromise| Ubisense
The Cold Chain Crisis: How Pharma Companies Can Prevent Spoilage and Loss Pharmaceutical supply chains are under more scrutiny than ever before. Among the most fragile elements is the cold chain: a temperature-controlled logistics process critical to preserving the efficacy of vaccines, biologics, cell and gene therapies, and other temperature-sensitive drugs. As global demand| Ubisense
And more biotech news brought to you by The Readout.| STAT
See how the UK's £225m Isambard-AI supercomputer is set to revolutionize drug and vaccine development using cutting-edge AI technology.| AI Accelerator Institute
Discover how the NHS’s GOSH is using large language models and AI to transform pediatric healthcare, improving outcomes for rare disease treatments.| AI Accelerator Institute
If approved, AP301 could potentially address two unmet needs in HP management: poor patient adherence and inadequate phosphorus control, says GlobalData.| GlobalData
CANNES – The promise of AI-powered creative versioning and real-time optimization in healthcare marketing faces a fundamental obstacle: regulatory review processes that haven�...| Beet.TV - The Root to the Media Revolution
CANNES – The fragmentation that has long plagued television advertising may finally be giving way to consolidation, creating new opportunities for precision targeting in healthc...| Beet.TV - The Root to the Media Revolution
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy| STAT
The $100 Billion Secret: Why Leading Pharma Companies Outsource Their Commercial Data Teams| DataKitchen
After making gains in 2022, multinational corporations will prioritise strengthening local partnerships to support their ambition of transforming the treatment landscape – but they are also pleading for further legal clarity.| Vietnam Investment Review - VIR
AstraZeneca announced May 7th it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. A request to withdraw it from European markets had been filed since March The company also proceeded to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. It submitted a withdrawal […] The post Astrazeneca Withdraws The Covid-19 Vaccine From All Markets Because Of Declining Demand appeared first on He...| Healthcare Weekly
Amgen announced May 2nd financial results for the first quarter 2024, and its shares soared right after the announcement, which was followed closely by a FDA approval of a lung-cancer drug. “With many of our innovative products delivering strong growth and promising new medicines advancing through our pipeline, we are excited about delivering attractive long-term […] The post Amgen Shares Value Rose After Financial Results And New Drug Related Announcement appeared first on Healthcare Wee...| Healthcare Weekly
A new Alzheimer’s treatment could cost Medicare billions of dollars by next year — well over Wall Street or even the drug’s manufacturer projections — according to a document obtained by STAT. 5.5 million people in the U.S. suffer from Alzheimer’s disease Declining general health is natural as one grows older. However, struggling with Alzheimer’s […] The post A New Alzheimer’s Treatment Could Cost Medicare Billions of Dollars by 2025 appeared first on Healthcare Weekly.| Healthcare Weekly
AI can create models that predict a compound’s potential and run this model on millions of compounds to find the most promising options.| AI Accelerator Institute
Discover how generative AI is transforming drug discovery, medical imaging, and patient outcomes to accelerate advancements with AstraZeneca| AI Accelerator Institute
An Interview with Dr. Robert Seik, PharmD When big Pharma sold American out for Covid Profits and politics by denying treatment, independent pharmacists saved the day. Are big chain pharmacies a risk to national security? What else have our medical establishments been hiding? When big business stands in the way to good health, it’s time […] The post Independant Pharmacies Saved America appeared first on Broken Truth.| Broken Truth
Marketing Masterminds discusses how to find the top pharmaceutical sales recruiters for growing teams. Where to get the best big pharma RX sellers.| www.marketingmasterminds.org
We can’t wait for others to find a solution to high drug prices. It’s clear what should happen in a functioning drug pricing market federally and in California, but it is not happening today.| MedCity News
